Partnerships

ACCELERATE is a multistakeholder paediatric oncology platform bringing together academia, industry, advocacy and regulators to find solutions for more and better innovative therapies for children and adolescents with cancer. ITCC is a founding member of ACCELERATE and member of the Board of Directors.

ITCC-P4 gGmbH is the first and only non-profit company worldwide to offer academic institutions, biotech and pharmaceutical companies, access to a comprehensive repertoire of 400+ fully characterized paediatric tumour models for systematic efficacy testing. The aim is to systematically test new treatment options for children and adolescents with cancer and generate data to regulatory approval processes in order to make the development of new cancer therapies for children and adolescents more attractive to pharmaceutical companies and academic research institutions. 

To help raise awareness of the importance and specific features of innovation in pediatric cancer treatment; facilitate access by innovation projects to pediatric cancer experts over Europe; support and guide the innovation projects to accelerate the development of solutions against pediatric cancers. ITCC and PSCC signed a MoU.

To closely collaborate with C17 Council in Canada. to facilitate the implementation of paediatric and adolescent trials in their respective network of clinical centers. The international collaboration is aiming at increasing and speeding up the accrual for the AYA population. ITCC signed a MoU with each of these groups. The goal is to further expand worldwide. 

To closely collaborate with the Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) to facilitate the implementation of paediatric and adolescent trials in their respective network of clinical centers. The international collaboration is aiming at increasing and speeding up the accrual for the AYA population. ITCC signed a MoU with each of these groups. The goal is to further expand worldwide. 

To aggregate data from (inter)national pediatric cancer clinical sequencing programs to make these data accessible in a harmonized and straightforward way as part of the ITCC Strategy. This program is piloted by KiTZ and funded by Dietmar Hopp Foundation.